Search Results - "Toublanc, Nathalie"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Development of an Integrated Population Pharmacokinetic Model for Oral Levetiracetam in Populations of Various Ages and Ethnicities by Toublanc, Nathalie, Lacroix, Brigitte D., Yamamoto, Junichi

    “…Levetiracetam [E Keppra®] is a second generation antiepileptic drug for different types of epilepsy in adults and children ≥1 month. The objective is to…”
    Get full text
    Journal Article
  2. 2

    Levetiracetam Intravenous Infusion: A Randomized, Placebo‐controlled Safety and Pharmacokinetic Study by Ramael, Steven, Daoust, Agnès, Otoul, Christian, Toublanc, Nathalie, Troenaru, Mona, Lu, Zhihong (Sarah), Stockis, Armel

    Published in Epilepsia (Copenhagen) (01-07-2006)
    “…Purpose: The primary objective of this placebo‐controlled study was to evaluate the safety and tolerability of levetiracetam (LEV) administered intravenously…”
    Get full text
    Journal Article
  3. 3

    Development of an Integrated Population Pharmacokinetic Model for Oral Levetiracetam in Populations of Various Ages and Ethnicities by Nathalie TOUBLANC, Brigitte D.LACROIX, Junichi YAMAMOTO

    Published in DRUG METABOLISM AND PHARMACOKINETICS (25-02-2014)
    “…[Summary] Levetiracetam [E Keppra(R)(R)] is a second generation antiepileptic drug for different types of epilepsy in adults and children >1 month. The…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Levetiracetam Pharmacokinetics in Japanese Subjects with Renal Impairment by Yamamoto, Junichi, Toublanc, Nathalie, Kumagai, Yuji, Stockis, Armel

    Published in Clinical drug investigation (01-11-2014)
    “…Background and Objective The anti-epileptic drug levetiracetam is excreted renally. The objective of this trial was to evaluate the pharmacokinetics of…”
    Get full text
    Journal Article
  6. 6

    Retrospective Population Pharmacokinetic Analysis of Levetiracetam in Children and Adolescents with Epilepsy: Dosing Recommendations by Toublanc, Nathalie, Sargentini-Maier, Maria Laura, Lacroix, Brigitte, Jacqmin, Philippe, Stockis, Armel

    Published in Clinical pharmacokinetics (01-01-2008)
    “…Objective: To characterize levetiracetam pharmacokinetics, identify significant covariate relationships and identify doses in children that achieve blood…”
    Get full text
    Journal Article
  7. 7

    Pharmacokinetics, Safety and Bioequivalence of Levetiracetam Intravenous Infusion and Oral Tablets in Healthy Chinese Subjects by Toublanc, Nathalie, Du, Xinlu, Liu, Yun, Chen, Qian, Singh, Pritibha, Chan, Robert, Stockis, Armel

    Published in Clinical drug investigation (01-08-2015)
    “…Background and Objective Levetiracetam is available in China as adjunctive oral therapy for partial-onset seizures. This study was conducted to evaluate the…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Seletracetam (UCB 44212) by Bennett, Barbara, Matagne, Alain, Michel, Philippe, Leonard, Michèle, Cornet, Miranda, Meeus, Marie-Anne, Toublanc, Nathalie

    Published in Neurotherapeutics (2007)
    “…Better pharmacotherapies for epilepsy are needed for patients who are refractory to or have tolerability difficulties with current treatments. Seletracetam, a…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Population pharmacokinetic-pharmacodynamic modeling of moxonidine using 24-hour ambulatory blood pressure measurements by Hempel, Georg, Karlsson, Mats O., Alwis, Dinesh P., Toublanc, Nathalie, McNay, John, Schaefer, Hans G.

    Published in Clinical pharmacology and therapeutics (01-12-1998)
    “…Objectives To develop a model for 24‐hour ambulatory blood pressure measurements (ABPM) that can be applied in a pharmacokinetic‐pharmacodynamic model. Methods…”
    Get full text
    Journal Article
  15. 15